
Context Therapeutics to Showcase CT-95 Data at AACR 2025
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced that new research on its clinical asset, CT-95, will be unveiled at the American Association for Cancer Research (AACR) Annual Meeting …
Context Therapeutics to Showcase CT-95 Data at AACR 2025 Read More